200 results
8-K
EX-99.1
DVAX
Dynavax Technologies Corp.
8 May 24
Dynavax Reports First Quarter 2024 Financial Results
4:05pm
., and the vast majority remaining unvaccinated,” said Ryan Spencer, Chief Executive Officer of Dynavax.
“We’re also excited for several upcoming milestones from … a majority market share.
Clinical Pipeline
Dynavax is advancing a pipeline of differentiated product candidates that leverage its CpG 1018® adjuvant, which
8-K
EX-99.1
xt5p6gqzjougbc8n6aw4
22 Feb 24
Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results
4:05pm
8-K
EX-99.1
565hbmtrl35vmwmw4xr
8 Jan 24
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
9:05am
S-3ASR
r3o6hq h8y1wmrmjcd8
3 Aug 23
Automatic shelf registration
5:26pm
S-3ASR
EX-4.8
gzz11n4iz
3 Aug 23
Automatic shelf registration
5:26pm
8-K
EX-99.1
l1d2k0r4vtc19
3 Aug 23
Dynavax Reports Second Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
4:11pm
8-K
EX-99.1
9z6fck
2 May 23
Dynavax Reports First Quarter 2023 Financial Results
4:11pm
8-K
EX-99.1
wcjf11i
5 May 22
Dynavax Reports First Quarter 2022 Financial Results
4:04pm